People in the industry believe that with the current transformation and maturation of the market for medicines and health products, the market for health products under the guidance of “non-therapeutic concepts†has begun to show a trend of vigorous development. Experts believe that compared with the traditional Chinese medical and pharmaceutical market, which is mainly treated, the Chinese herbal medicine market under this non-therapeutic concept has hidden huge business opportunities, which is an opportunity for the cultivation and development of the current Chinese herbal medicine market.
Wang Laoji's Development Brings Reflections on Chinese Medicine Industry
At the 2008 Angelica Industrial Forum held in Ji County, Gansu Province, the Green Industry Standards Office of the China Medicare Association provided a set of data: Wang Laoji’s sales were RMB 180 million in 2002, RMB 600 million in 2003, and RMB 1.43 billion in 2004. In 2005, it was 2.5 billion yuan, and in 2006 it was nearly 4 billion yuan. According to reports, Guangzhou Wong Lo Kat Group's main products are Wong Lo Kat series, Po Chai Pills, Bao Ji oral liquid, children Qixing tea, heat acne tablets, Kegan Liyan oral liquid, Cough cough net, Bile pills, etc., including Wong Lo Kat herbal tea , Wong Lo Kat Guangdong Liangcha Granules, etc. have been rated as "Guangdong Province, Guangzhou City, brand-name products" and "Chinese medicine brand-name products." Experts at the meeting pointed out that the development and growth of Wong Lo Kat brings a reflection to the Chinese medicine industry in China: The non-therapeutic concept will bring tremendous development opportunities to the Chinese medicine industry.
Some experts pointed out that according to the thinking of the development of traditional Chinese medicines in the past, the development of Chinese herbal medicines must be combined with clinical medical care, that is, to provide medical institutions with Chinese and Western medicines that can treat diseases. In this case, the market is very single, so the Chinese herbal medicines How destiny is determined solely by the health care institutions. They believe that although the liberalization of the non-prescription drug market has injected vitality into the Chinese herbal medicine market, drugs are drugs after all. Its market consumption targets only patients. With the current popularization and deepening of people’s health concepts and knowledge, the market for pharmaceuticals is pure. Do not dare to say shrinkage, at least not significantly.
Health product market has broad prospects
Some industry sources pointed out that health products should be the main direction for the development of the Chinese herbal medicine market in the future.
First of all, from the target population, the market for health products is promising. Experts from the China Greenhouses Chamber of Commerce’s Green Industry Standards Office pointed out that if the human health is divided into four stages: undiseased, unwell, illness and rehabilitation, then only a variety of Chinese and Western medicines are needed for treatment at the stage of illness, and no illness or body Not suitable for rehabilitation, all need to use a variety of health products to nurse. According to research released by the World Health Organization, 15% of the world’s population is in a state of disease, 70% of the population is in a sub-health state, and sub-healthy and healthy people are the main consumers of health products. Therefore, the target population of health products is much larger than drug.
Second, from the perspective of market share, health care products are a rapidly emerging field. According to the data provided by the Green Industry Standards Office of China Medical Insurance Association, the global health food sales in 2006 reached 70 billion U.S. dollars, and the growth rate was about 7%. By 2010, the market capacity will reach 100 billion U.S. dollars. In China, the total sales of health food products in China in 2005 was around 80 billion yuan, which is approximately 61 yuan per person per year on a per capita basis, and it is more than 1,000 yuan per person per year in economically developed areas.
Third, the unique concept of cultivation of Chinese herbal medicine and traditional Chinese medicine is applicable to the "green" requirements of the health care product market. Traditional Chinese herbal medicines grow in natural environments. Even the current large-scale planting of algae can guarantee the characteristics of natural plants. At present, consumers have higher requirements for the "green" quality of finished products and upstream products of Chinese herbal medicines. To a large extent this requirement can be met.
Chinese medicine industry faces further challenges
With the global economic integration, domestic companies have become increasingly urgent and need to participate in international competition and gain more space for development. However, looking at the exports of Chinese herbal medicines and traditional Chinese medicine products, the situation is not optimistic. Except that some countries use administrative and technical barriers to double block the export of Chinese medicine, the competitiveness of China's pharmaceutical industry itself is not high, and Chinese medicine companies are lacking in international market development. The further growth of the Chinese medicine industry has also brought with it certain difficulties.
According to Xu Ming, Director of the General Department of the Chinese Medicine and Health Products Import and Export Chamber of Commerce and Dr. Ming of Industrial Economics at Fudan University, the total output value of the pharmaceutical industry in China was 194.46 billion yuan in 2000, and it was 553.69 billion yuan in 2006. Meanwhile, the import and export volume also increased accordingly. However, under such circumstances, China's pharmaceutical industry companies have small scale, low industrial concentration, low industrial operation efficiency, and unfavorable factors affecting industrial development. He introduced that in 2000, the number of large companies in China's pharmaceutical industry was 284. By 2005, it had decreased to 55, from 7.35% to 0,97%. From 2000 to 2006, the gross profit of China's pharmaceutical industry dropped from 36.9% to 30%. The profit margin of the pharmaceutical industry declined from 9.4% in 2005 to 8.5%. These data show that the scale and benefits of China's overall pharmaceutical industry have gradually declined.
Xu Ming and other experts pointed out that the current situation has caused the overall fluctuations in the international pharmaceutical market, but also exposed China's pharmaceutical industry innovation, brand and other aspects of deficiencies. In the face of international competition, China's state-owned pharmaceutical industry will also face a new wave of cross-border mergers and acquisitions. Japan and South Korea’s plant drug companies will take the lead in challenging domestic manufacturers of Chinese herbal medicines, and more and more foreign Chinese medicines will rush to the domestic market. .
Developing TCM Industry to Transform Quality and Efficiency
The Chinese medicine industry involves agriculture, Chinese medicine industry, Chinese medicine business, and Chinese medicine knowledge industry. It is a complete industrial chain. Traditional Chinese medicine is the basic raw material of TCM clinical and TCM industry, and it is an important strategic resource for sustainable development in China. Therefore, it is of great practical significance to develop the cultivation of traditional Chinese medicine, promote the formation of traditional Chinese medicine agriculture and its standardization and intensive development, thereby improving the development chain of the traditional Chinese medicine industry, protecting important resources and ensuring the sustainable development of the traditional Chinese medicine industry.
Zou Jianqiang, an expert from the Ministry of Science and Social Development, pointed out that the following issues should be addressed in the development of the planting industry in the upper reaches of Chinese herbal medicines:
First, science and technology must be implemented first, and the scale of production should be further expanded on the basis of establishing standards and standards and ensuring product quality. Traditional Chinese medicine is a typical traditional industry, especially the cultivation of Chinese herbal medicines. To change from extensive production methods to quality-effective ones, modern technologies must be used to support and transform them. Through the improvement of Chinese herbal medicine standards to form brands, the quality of Chinese herbal medicines can be improved to improve efficiency.
The second is to actively research and develop new products that use local characteristic Chinese medicinal materials as raw materials and increase the added value of Chinese medicine resources. Through technological innovation, we will develop as many end products as possible, such as the “secondary development†of traditional Chinese medicine and the research and development of modern Chinese medicine, health products, daily necessities, cosmetics, food additives using traditional Chinese medicines as raw materials, and pesticides, veterinary drugs, feed additives, etc. Green product development.
According to Xu Ming, the director of the General Department of the China Import and Export Chamber of Commerce for the Import and Export of Medicinal Health Products and the Doctor of Economics at Fudan University, there are several points worthy of referring to the case of Tong Ren Tang’s internationalization: the first is to promote the internationalization of products with the brand effect; the second is more perfect. The corporate governance structure has strongly promoted the internationalization process. Third, the intensive operation of production, supply and sales is the fundamental guarantee for internationalization. Fourth, the direct investment method of setting up branches has made remarkable achievements in opening up the international market. Fifth, it has built on the dominant position of Hong Kong to enter the international market. Fast track; Sixth, continuous innovation provides the impetus for internationalization; Seventh, continuous implementation of talent development strategy.
The experts of the China Green Insurance Industry Association’s Green Industry Standards Office also believe that it is also necessary to promote the export management of Chinese medicine through the green standard certification of the products of Chinese medicine export companies in order to reflect the dominant position of Chinese medicine in world medicine, increase the international competitiveness of Chinese medicine in China. of.
Wang Laoji's Development Brings Reflections on Chinese Medicine Industry
At the 2008 Angelica Industrial Forum held in Ji County, Gansu Province, the Green Industry Standards Office of the China Medicare Association provided a set of data: Wang Laoji’s sales were RMB 180 million in 2002, RMB 600 million in 2003, and RMB 1.43 billion in 2004. In 2005, it was 2.5 billion yuan, and in 2006 it was nearly 4 billion yuan. According to reports, Guangzhou Wong Lo Kat Group's main products are Wong Lo Kat series, Po Chai Pills, Bao Ji oral liquid, children Qixing tea, heat acne tablets, Kegan Liyan oral liquid, Cough cough net, Bile pills, etc., including Wong Lo Kat herbal tea , Wong Lo Kat Guangdong Liangcha Granules, etc. have been rated as "Guangdong Province, Guangzhou City, brand-name products" and "Chinese medicine brand-name products." Experts at the meeting pointed out that the development and growth of Wong Lo Kat brings a reflection to the Chinese medicine industry in China: The non-therapeutic concept will bring tremendous development opportunities to the Chinese medicine industry.
Some experts pointed out that according to the thinking of the development of traditional Chinese medicines in the past, the development of Chinese herbal medicines must be combined with clinical medical care, that is, to provide medical institutions with Chinese and Western medicines that can treat diseases. In this case, the market is very single, so the Chinese herbal medicines How destiny is determined solely by the health care institutions. They believe that although the liberalization of the non-prescription drug market has injected vitality into the Chinese herbal medicine market, drugs are drugs after all. Its market consumption targets only patients. With the current popularization and deepening of people’s health concepts and knowledge, the market for pharmaceuticals is pure. Do not dare to say shrinkage, at least not significantly.
Health product market has broad prospects
Some industry sources pointed out that health products should be the main direction for the development of the Chinese herbal medicine market in the future.
First of all, from the target population, the market for health products is promising. Experts from the China Greenhouses Chamber of Commerce’s Green Industry Standards Office pointed out that if the human health is divided into four stages: undiseased, unwell, illness and rehabilitation, then only a variety of Chinese and Western medicines are needed for treatment at the stage of illness, and no illness or body Not suitable for rehabilitation, all need to use a variety of health products to nurse. According to research released by the World Health Organization, 15% of the world’s population is in a state of disease, 70% of the population is in a sub-health state, and sub-healthy and healthy people are the main consumers of health products. Therefore, the target population of health products is much larger than drug.
Second, from the perspective of market share, health care products are a rapidly emerging field. According to the data provided by the Green Industry Standards Office of China Medical Insurance Association, the global health food sales in 2006 reached 70 billion U.S. dollars, and the growth rate was about 7%. By 2010, the market capacity will reach 100 billion U.S. dollars. In China, the total sales of health food products in China in 2005 was around 80 billion yuan, which is approximately 61 yuan per person per year on a per capita basis, and it is more than 1,000 yuan per person per year in economically developed areas.
Third, the unique concept of cultivation of Chinese herbal medicine and traditional Chinese medicine is applicable to the "green" requirements of the health care product market. Traditional Chinese herbal medicines grow in natural environments. Even the current large-scale planting of algae can guarantee the characteristics of natural plants. At present, consumers have higher requirements for the "green" quality of finished products and upstream products of Chinese herbal medicines. To a large extent this requirement can be met.
Chinese medicine industry faces further challenges
With the global economic integration, domestic companies have become increasingly urgent and need to participate in international competition and gain more space for development. However, looking at the exports of Chinese herbal medicines and traditional Chinese medicine products, the situation is not optimistic. Except that some countries use administrative and technical barriers to double block the export of Chinese medicine, the competitiveness of China's pharmaceutical industry itself is not high, and Chinese medicine companies are lacking in international market development. The further growth of the Chinese medicine industry has also brought with it certain difficulties.
According to Xu Ming, Director of the General Department of the Chinese Medicine and Health Products Import and Export Chamber of Commerce and Dr. Ming of Industrial Economics at Fudan University, the total output value of the pharmaceutical industry in China was 194.46 billion yuan in 2000, and it was 553.69 billion yuan in 2006. Meanwhile, the import and export volume also increased accordingly. However, under such circumstances, China's pharmaceutical industry companies have small scale, low industrial concentration, low industrial operation efficiency, and unfavorable factors affecting industrial development. He introduced that in 2000, the number of large companies in China's pharmaceutical industry was 284. By 2005, it had decreased to 55, from 7.35% to 0,97%. From 2000 to 2006, the gross profit of China's pharmaceutical industry dropped from 36.9% to 30%. The profit margin of the pharmaceutical industry declined from 9.4% in 2005 to 8.5%. These data show that the scale and benefits of China's overall pharmaceutical industry have gradually declined.
Xu Ming and other experts pointed out that the current situation has caused the overall fluctuations in the international pharmaceutical market, but also exposed China's pharmaceutical industry innovation, brand and other aspects of deficiencies. In the face of international competition, China's state-owned pharmaceutical industry will also face a new wave of cross-border mergers and acquisitions. Japan and South Korea’s plant drug companies will take the lead in challenging domestic manufacturers of Chinese herbal medicines, and more and more foreign Chinese medicines will rush to the domestic market. .
Developing TCM Industry to Transform Quality and Efficiency
The Chinese medicine industry involves agriculture, Chinese medicine industry, Chinese medicine business, and Chinese medicine knowledge industry. It is a complete industrial chain. Traditional Chinese medicine is the basic raw material of TCM clinical and TCM industry, and it is an important strategic resource for sustainable development in China. Therefore, it is of great practical significance to develop the cultivation of traditional Chinese medicine, promote the formation of traditional Chinese medicine agriculture and its standardization and intensive development, thereby improving the development chain of the traditional Chinese medicine industry, protecting important resources and ensuring the sustainable development of the traditional Chinese medicine industry.
Zou Jianqiang, an expert from the Ministry of Science and Social Development, pointed out that the following issues should be addressed in the development of the planting industry in the upper reaches of Chinese herbal medicines:
First, science and technology must be implemented first, and the scale of production should be further expanded on the basis of establishing standards and standards and ensuring product quality. Traditional Chinese medicine is a typical traditional industry, especially the cultivation of Chinese herbal medicines. To change from extensive production methods to quality-effective ones, modern technologies must be used to support and transform them. Through the improvement of Chinese herbal medicine standards to form brands, the quality of Chinese herbal medicines can be improved to improve efficiency.
The second is to actively research and develop new products that use local characteristic Chinese medicinal materials as raw materials and increase the added value of Chinese medicine resources. Through technological innovation, we will develop as many end products as possible, such as the “secondary development†of traditional Chinese medicine and the research and development of modern Chinese medicine, health products, daily necessities, cosmetics, food additives using traditional Chinese medicines as raw materials, and pesticides, veterinary drugs, feed additives, etc. Green product development.
According to Xu Ming, the director of the General Department of the China Import and Export Chamber of Commerce for the Import and Export of Medicinal Health Products and the Doctor of Economics at Fudan University, there are several points worthy of referring to the case of Tong Ren Tang’s internationalization: the first is to promote the internationalization of products with the brand effect; the second is more perfect. The corporate governance structure has strongly promoted the internationalization process. Third, the intensive operation of production, supply and sales is the fundamental guarantee for internationalization. Fourth, the direct investment method of setting up branches has made remarkable achievements in opening up the international market. Fifth, it has built on the dominant position of Hong Kong to enter the international market. Fast track; Sixth, continuous innovation provides the impetus for internationalization; Seventh, continuous implementation of talent development strategy.
The experts of the China Green Insurance Industry Association’s Green Industry Standards Office also believe that it is also necessary to promote the export management of Chinese medicine through the green standard certification of the products of Chinese medicine export companies in order to reflect the dominant position of Chinese medicine in world medicine, increase the international competitiveness of Chinese medicine in China. of.
We are manufacturer of heat treated steel pipes include quenched and tempered steel pipe, normalized steel pipe and annealed steel pipe among carbon steel pipe and alloy steel pipe. Our advantages and more services of heat treated steel pipes includes:
1) Wide range of sizes, out diameter from 20mm to 100mm
2) Customized Length from 100mm to 12000mm
3) Good surface roughness: 0.4um to 1.5um
4) Good straightness: 0.5mm/m to 2mm/m
5) Matched further processing: Grinding, polishing, straightening
5) Anti-rusty package
7) Full sets of testing equipment: Surface, Dimenstion. Mechanical properties testing
8) Fast delivery time
4130 Pipe,Steel Tubing,Seamless Pipe,Annealed Tubing
SHANDONG LE REN SPECIAL STEEL CO., LTD. , https://www.sdthreadedrods.com